Mersana Therapeutics, Inc. (MRSN)
Q1 2019 Earnings Conference Call
May 09, 2019, 08:00 AM ET
Company Participants
Sarah Carmody - IR and Corporate Communications
Anna Protopapas - CEO
Tim Lowinger - Chief Scientific Officer
Dave Spellman - CFO
Eva Jack - Chief Business Officer
Dirk Huebner - CMO
Conference Call Participants
Jonathan Chang - SVB Leerink
Jessica Fye – JPMorgan
Presentation
Operator
Good morning and welcome to the Mersana Therapeutics’ First Quarter 2019 Conference Call. Currently, all participants are in a listen-only mode. There will be a question-and-answer session at the end of this call.